Clinical Trial Update: Pharmacokinetics of Multiple Ascending Doses of VCH-222 in Subjects With Chronic Hepatitis C Infection [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update describing pharmacokinetics results from multiple ascending doses of VCH-222 in subjects with chronic hepatitis C (Phase 1/2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• VCH-222

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Hepatitis C | Phase 1, Phase 2 | Status: COMPLETED